Al Kildani
Senior Vice President, Investor Relations and Corporate Communications, Acadia Pharmaceuticals
Replay available
ACADIA Pharmaceuticals Inc. (ACAD) Q3 2025 Earnings Call
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) Q3 2025 earnings conference call, held 2025-11-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Catherine Owen-Adams
Chief Executive Officer, Acadia Pharmaceuticals
Tom Garner
Chief Commercial Officer, Acadia Pharmaceuticals
Mark Schneier
Chief Financial Officer, Acadia Pharmaceuticals
Ritu Barrow
Analyst, TD Cowan
Yigal Notramoffitz
Analyst, Citigroup
Tess Romero
Analyst, J.P. Morgan
Brian Abrahams
Analyst, RBC Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Acadia Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:02.995 Good day, ladies and gentlemen, and thank you for standing by. 00:00:02.995 -- 00:00:08.243 Welcome to Acadia Pharmaceuticals' third quarter 2025 financial 00:00:08.243 -- 00:00:13.370 results conference call. At this time, all participants are in a listen-only 00:00:13.370 -- 00:00:18.738 mode. After the speaker's presentation, there will be a question and answer session. 00:00:18.738 -- 00:00:23.885 To ask a question during the session, you will need to press star 11 on your 00:00:23.885 -- 00:00:29.248 telephone. Please be advised that today's conference is being recorded. 00:00:29.248 -- 00:00:34.154 I would now like to hand the conference over to Al Kildani, Senior Vice President of 00:00:34.154 -- 00:00:38.379 Investor Relations and Corporate Communications at Acadia. 00:00:38.379 -- 00:00:40.840 Please go ahead. 00:00:42.304 -- 00:00:46.389 Good afternoon, and thank you for joining us on today's call to discuss Acadia's third 00:00:46.389 -- 00:00:49.863 quarter 2025 financial results. 00:00:49.863 -- 00:00:54.108 Joining me on the call today from Acadia are Catherine Owen-Adams, our Chief Executive 00:00:54.108 -- 00:00:58.995 Officer, who will provide some opening remarks, followed by Tom Garner, our Chief Commercial 00:00:58.995 -- 00:01:03.140 Officer, who will discuss our commercial brand, Debut and New Plazit. 00:01:03.140 -- 00:01:07.766 Also joining us today is Elizabeth Thompson, Ph.D., Executive Vice President, Head of 00:01:07.766 -- 00:01:12.331 Research and Development, who will provide an update on our pipeline programs, and Mark 00:01:12.331 -- 00:01:16.576 Schneier, our Chief Financial Officer, who will review the financial highlights. 00:01:16.576 -- 00:01:19.759 Catherine will then provide some closing thou...